The global infectious testing market is experiencing robust growth due to advancements in diagnostic technologies and increased emphasis on early disease detection. Innovations such as next-generation sequencing and advanced molecular diagnostics are revolutionizing the field by offering more precise and rapid results. The market is also being driven by the rising incidence of infectious diseases and supportive healthcare policies that promote widespread testing. Additionally, the expansion of point-of-care testing solutions is improving accessibility and convenience for both patients and healthcare providers. The integration of digital technologies and AI in diagnostic tools is further enhancing the accuracy and efficiency of infectious testing, fueling continued market expansion. With ongoing research and development efforts, the market is set to benefit from more sophisticated testing methods and increased adoption across various healthcare settings.
